(S)-2-Amino-6-(((R)-1-(((R)-1-carboxy-2-methylpropyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-6-oxohexanoic acid

Catalog No. :
ACZRUJ655
CAS No. :
32467-88-2
Molecular Formula :
C14H25N3O6S
Molecular Weight :
363.44

IUPAC Name:ACV Tripeptide

(S)-2-Amino-6-(((R)-1-(((R)-1-carboxy-2-methylpropyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-6-oxohexanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$158.00Login to see priceInquiryInquiry
5mg98%$397.00Login to see priceInquiryInquiry
10mg98%$636.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-Amino-6-(((R)-1-(((R)-1-carboxy-2-methylpropyl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-6-oxohexanoic acid
IUPAC NameACV Tripeptide
Molecular FormulaC14H25N3O6S
Molecular Weight363.44
SMILESCC(C)[C@H](C(O)=O)NC([C@H](CS)NC(CCC[C@H](N)C(O)=O)=O)=O
InChI KeyBYEIJZFKOAXBBV-ATZCPNFKSA-N
SynonymN-[(5s)-5-Amino-5-Carboxy-1-Oxopentyl]-L- Cysteinyl-D-Valine;ACV trifluoroacetate salt H-Aad (Cys-D-Val-OH)-OH trifluoroacetate salt;D-valine, N-[(5S)-5-amino-5-carboxy-1-oxopentyl]-L-cysteinyl-;d-(L-a-AMinoadipyl)-L-cysteinyl-D-valine;Acv tripeptide;ACV/δ-(L-α-Aminoadipyl)-L-cysteinyl-D-valine;δ-(L-α-Aminoadipyl)-L-cysteinyl-D-valine;(2S)-2-amino-6-[[(2R)-1-[[(1R)-1-carboxy-2-methylpropyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-6-oxohexanoic acid
CAS No.32467-88-2

Synthetic Route by SureRoute

1. ACZRUJ655 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZRUJ655 route product structure diagram
    ACZRUJ65532467-88-2
Inquiry

2. ACZRUJ655 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZRUJ655 route product structure diagram
    ACZRUJ65532467-88-2
Inquiry

Comments (0)